50
Participants
Start Date
September 14, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
TetraGraph
FDA approved neuromuscular transmission monitor capable of measuring the depth of neuromuscular block in anesthetized patients who received neuromuscular blocking agents. TetraGraph uses EMG to measure the muscle action potentials that are generated in response to electrical neurostimulation via skin electrodes.
Mayo Clinic in Florida, Jacksonville
Lead Sponsor
Mayo Clinic
OTHER